Cartio Therapeutics

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttp://cartio.com/

Company Overview

Cartio Therapeutics is a biotechnology company developing chimeric antigen receptor (CAR) regulatory T cell therapies to treat atherosclerosis and other cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR Treg therapycellular immunotherapyatherosclerosis treatmentregulatory T cellTregcell therapycardiovascular diseaseanti-oxLDLbiotech startuppreclinical researchnext-gen immunotherapyprecision medicinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cartio Therapeutics Comparables

Compare Cartio Therapeutics with similar companies based on industry and business-model similarity.

Cartio Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
POLYGON Therapeutics	72%
GentiBio	71%
Sonoma Biotherapeutics	66%

View all Comparables

Cartio Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Cartio Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cartio Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cartio Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Year Founded2024

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?